LDK378
Ceritinib is an orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity.
Product Specifications
CAS Number
1032900-25-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
558.14
Molecular Formula
C28H36ClN5O3S
Notes
Research use only, not for human use.
Receptor
ALK| FLT3| IGF-1R| Insulin Receptor| STK22D
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
